Mihir Khunte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mihir Khunte has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Malhotra
Department of Radiology, Yale New Haven Hospital, CT (A.M.).
36 shared publications - Dheeraj Gandhi
Division of Neurointerventional Surgery, Department of Neurosurgery, University of Maryland Medical Center, Baltimore (H.C., D.G.).
24 shared publications - Huanwen Chen
Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
14 shared publications - Seyedmehdi Payabvash
Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA
14 shared publications - Marco Colasurdo
Department of Interventional Radiology (M.C.), Oregon Health and Science University, Portland
13 shared publications - Max Wintermark
Department of Radiology, The University of Texas Medical Branch, Galveston
10 shared publications
Latest Publications
- 27 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107  (8)
Author Response: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease
- 27 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107  (8)
Author Response: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease
- 27 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107  (8) , e213565
Author Response: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease
- 27 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107  (8) , e213565
Author Response: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319  (1) , e251983
Endovascular versus Medical Management of Basilar Artery Occlusion Strokes in Patients with Low Stroke Severity
Patients with basilar artery occlusion strokes and low stroke severity had similar rates of routine discharge home to self-care, but higher in-hospital mortality with endovascular treatment versus medical management.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319  (1) , e251983
Endovascular versus Medical Management of Basilar Artery Occlusion Strokes in Patients with Low Stroke Severity
Patients with basilar artery occlusion strokes and low stroke severity had similar rates of routine discharge home to self-care, but higher in-hospital mortality with endovascular treatment versus medical management.
- 3 June 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46  (6) , 1093-1099
Gender Differences in Medicare Practice and Payment of Neuroradiologists
Female neuroradiologists in clinical practice are outnumbered by their male counterparts. However, it is unknown whether there are differences in practice patterns and Medicare billing and payment between female and male neuroradiologists. Our aim was to compare representation, practice range, clinical productivity, and Medicare payments for female and male neuroradiologists. A retrospective cross-sectional study of Medicare provider and service data was conducted. Male and female neuroradiologists who received Medicare payments from 2017 to 2021 and the services rendered were analyzed. Primary outcome was gender representation, mean payments received from Medicare, charges submitted, and codes billed. T tests and Mann-Whitney U tests were used to determine differences in payment and practice volume between male and female radiologists. From 2017 to 2021, there were a total of 2701 neuroradiologists, of whom 526 (19.5%) were female, with a higher proportion of women in academic than nonacademic neuroradiology practice (23.3% versus 15.6%, respectively). On average, female neuroradiologists charged less (mean, standard error [SE], $642,489 [$14,756] versus $738,416 [$7800]; P < .001) and were paid less by Medicare (mean [SE], $92,834 [$1877] versus $113,495 [$1044]; P < .001) compared with their male counterparts. By contrast, female neuroradiologists had a higher payment-per-service ratio (mean [SE], 0.232 [0.001] versus 0.208 [0.0003]; P < .001). Women billed fewer median total services (1802; interquartile range [IQR], 925-4726] versus 2461 [IQR, 1268-5781]; P < .001), served fewer median beneficiaries (1232 [IQR, 705-1963] versus 1697 [IQR, 990-2682]; P < .001), and billed fewer median unique codes (19 [IQR, 13-26] versus 23 [IQR, 17-33]; P < .001). Temporal analysis of data across the 5-year study period showed that men consistently received higher payments than women, though the difference in mean Medicare charge (P = .03), mean Medicare payment (P = .04), and median number of services provided (P = .04) between the 2 cohorts is decreasing. Female neuroradiologists were underrepresented, charged less, and received less overall payment compared with their male counterparts. Female neuroradiologists provided a smaller range and number of services, and a greater proportion of female neuroradiologists billed for higher-paying services. Further studies are needed to assess differences in part-time work and subspecialty representation to determine their impact.
- 3 June 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46  (6) , 1093-1099
Gender Differences in Medicare Practice and Payment of Neuroradiologists
Female neuroradiologists in clinical practice are outnumbered by their male counterparts. However, it is unknown whether there are differences in practice patterns and Medicare billing and payment between female and male neuroradiologists. Our aim was to compare representation, practice range, clinical productivity, and Medicare payments for female and male neuroradiologists. A retrospective cross-sectional study of Medicare provider and service data was conducted. Male and female neuroradiologists who received Medicare payments from 2017 to 2021 and the services rendered were analyzed. Primary outcome was gender representation, mean payments received from Medicare, charges submitted, and codes billed. T tests and Mann-Whitney U tests were used to determine differences in payment and practice volume between male and female radiologists. From 2017 to 2021, there were a total of 2701 neuroradiologists, of whom 526 (19.5%) were female, with a higher proportion of women in academic than nonacademic neuroradiology practice (23.3% versus 15.6%, respectively). On average, female neuroradiologists charged less (mean, standard error [SE], $642,489 [$14,756] versus $738,416 [$7800]; P < .001) and were paid less by Medicare (mean [SE], $92,834 [$1877] versus $113,495 [$1044]; P < .001) compared with their male counterparts. By contrast, female neuroradiologists had a higher payment-per-service ratio (mean [SE], 0.232 [0.001] versus 0.208 [0.0003]; P < .001). Women billed fewer median total services (1802; interquartile range [IQR], 925-4726] versus 2461 [IQR, 1268-5781]; P < .001), served fewer median beneficiaries (1232 [IQR, 705-1963] versus 1697 [IQR, 990-2682]; P < .001), and billed fewer median unique codes (19 [IQR, 13-26] versus 23 [IQR, 17-33]; P < .001). Temporal analysis of data across the 5-year study period showed that men consistently received higher payments than women, though the difference in mean Medicare charge (P = .03), mean Medicare payment (P = .04), and median number of services provided (P = .04) between the 2 cohorts is decreasing. Female neuroradiologists were underrepresented, charged less, and received less overall payment compared with their male counterparts. Female neuroradiologists provided a smaller range and number of services, and a greater proportion of female neuroradiologists billed for higher-paying services. Further studies are needed to assess differences in part-time work and subspecialty representation to determine their impact.
- Top Cited Papers
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56  (6) , 1404-1412
Standalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma
BACKGROUND: Recent randomized control trials have demonstrated the efficacy and safety of middle meningeal artery embolization (MMAE) as an adjunct to conventional management for patients with nonacute subdural hematoma (SDH); however, a large majority of trial participants received surgical evacuation as part of the standard of care. Thus, the efficacy and safety of standalone MMAE compared with conservative management (CM) for patients with nonsurgical SDH are unclear. METHODS: This was a retrospective cohort study of the 2019 to 2021 Nationwide Readmissions Database in the United States. Patients with nonsurgical nontraumatic SDH were identified, and MMAE patients were matched with similar CM patients using propensity scores calculated from demographics, comorbidities, and initial hospitalization outcomes. Patients were followed up to 300 days. The primary end point was composite surgical rescue or death, and secondary end points included surgical rescue and all-cause mortality by 180 days. RESULTS: A total of 24 465 patients with nonsurgical nontraumatic SDH were identified; 2228 (9.1%) underwent MMAE. After propensity score matching, 6675 patients remained in the CM group and 2217 in the MMAE group. At 180 days, MMAE patients had a significantly lower risk of surgery or death compared with CM (8.2% versus 10.9%; relative risk, 0.75 [95% CI, 0.59–0.96]; P =0.022) and lower risk of death (1.1% versus 3.0%; relative risk, 0.38 [95% CI, 0.17–0.86]; P =0.020). Rates of surgical rescue among MMAE and CM patients at 180 days were similar (7.1% versus 8.4%; relative risk, 0.85 [95% CI, 0.63–1.14]; P =0.27). Time-to-event analyses for the entire 300-day study follow-up period confirmed that while MMAE was associated with a lower cumulative risk of all-cause mortality (hazard ratio, 0.55 [95% CI, 0.35–0.87]; P =0.010), it was not associated with a different risk of surgical rescue (hazard ratio, 1.00 [95% CI, 0.76–1.31]; P =1.00). CONCLUSIONS: Standalone MMAE may be beneficial for patients with nonsurgical nontraumatic SDH by reducing the long-term risk of all-cause mortality.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56  (6) , 1404-1412
Top Cited PapersStandalone Middle Meningeal Artery Embolization Versus Conservative Management for Nontraumatic Subdural Hematoma
BACKGROUND: Recent randomized control trials have demonstrated the efficacy and safety of middle meningeal artery embolization (MMAE) as an adjunct to conventional management for patients with nonacute subdural hematoma (SDH); however, a large majority of trial participants received surgical evacuation as part of the standard of care. Thus, the efficacy and safety of standalone MMAE compared with conservative management (CM) for patients with nonsurgical SDH are unclear. METHODS: This was a retrospective cohort study of the 2019 to 2021 Nationwide Readmissions Database in the United States. Patients with nonsurgical nontraumatic SDH were identified, and MMAE patients were matched with similar CM patients using propensity scores calculated from demographics, comorbidities, and initial hospitalization outcomes. Patients were followed up to 300 days. The primary end point was composite surgical rescue or death, and secondary end points included surgical rescue and all-cause mortality by 180 days. RESULTS: A total of 24 465 patients with nonsurgical nontraumatic SDH were identified; 2228 (9.1%) underwent MMAE. After propensity score matching, 6675 patients remained in the CM group and 2217 in the MMAE group. At 180 days, MMAE patients had a significantly lower risk of surgery or death compared with CM (8.2% versus 10.9%; relative risk, 0.75 [95% CI, 0.59–0.96]; P =0.022) and lower risk of death (1.1% versus 3.0%; relative risk, 0.38 [95% CI, 0.17–0.86]; P =0.020). Rates of surgical rescue among MMAE and CM patients at 180 days were similar (7.1% versus 8.4%; relative risk, 0.85 [95% CI, 0.63–1.14]; P =0.27). Time-to-event analyses for the entire 300-day study follow-up period confirmed that while MMAE was associated with a lower cumulative risk of all-cause mortality (hazard ratio, 0.55 [95% CI, 0.35–0.87]; P =0.010), it was not associated with a different risk of surgical rescue (hazard ratio, 1.00 [95% CI, 0.76–1.31]; P =1.00). CONCLUSIONS: Standalone MMAE may be beneficial for patients with nonsurgical nontraumatic SDH by reducing the long-term risk of all-cause mortality.
- Open Access
- 23 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15  (11) , 1308
Minimally Invasive Surgery Versus Conventional Neurosurgical Treatments for Patients with Subcortical Supratentorial Intracerebral Hemorrhage: A Nationwide Study of Real-World Data from 2016 to 2022
Background: Neurosurgical interventions are often indicated for patients with subcortical, supratentorial intracerebral hemorrhage (ICH); however, the optimal treatment modality is controversial. Whether minimally invasive surgery (MIS) may be superior to conventional craniotomy (CC) or decompressive craniectomy (DC) in real-world clinical practice is unknown. Methods: This was a retrospective cohort study of hospitalization data from the 2016–22 Nationwide Readmissions Database. International Classification of Diseases—10th edition (ICD-10) codes were used to identify patients with primary supratentorial subcortical ICH who underwent neurosurgical treatment. Patients with ICH in other brain compartments (other than intraventricular hemorrhage) were excluded. Coprimary outcomes were routine discharge to home without rehabilitation needs (excellent outcome) and in-hospital mortality. Outcomes were compared between MIS versus CC and MIS versus DC, with multivariable adjustments for patient demographics and comorbidities. Results: A total of 3829 patients were identified; 418 underwent MIS (10.9%), 2167 (56.6%) underwent CC, and 1244 (32.5%) underwent DC. Compared to CC patients, MIS patients were less likely female (p = 0.004) but otherwise had similar patient characteristics; compared to DC patients, MIS patients were older, less likely female, more likely to have mental status abnormalities, more likely to have underlying dementia, less likely to undergo external ventricular drainage, more likely to have vascular risk factors (hypertension, hyperlipidemia, diabetes), and less likely to have underlying coagulopathy (all p < 0.05). After multivariable adjustments, MIS patients had higher odds of excellent outcomes compared to CC (OR 1.99 [95%CI 1.06–3.30], p = 0.039), and similar odds compared to DC (OR 1.10 [95%CI 0.66–1.86], p = 0.73). In terms of in-hospital mortality, MIS had lower odds compared to DC (OR 0.63 [95%CI 0.41–0.96], p = 0.032) and similar odds compared to CC (OR 0.81 [95%CI 0.56–1.18], p = 0.26). Conclusions: For patients with subcortical, supratentorial ICH requiring surgical evacuation, MIS was associated with higherhigher rates of excellent outcomes compared to CC and lower rates of in-hospital mortality compared to DC. However, since key variables such as hematoma size and symptom severity were not available, residual confounding could not be excluded, and results should be interpreted cautiously. Dedicated prospective or randomized studies are needed to confirm these findings.
- 23 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15  (11) , 1308
Open AccessMinimally Invasive Surgery Versus Conventional Neurosurgical Treatments for Patients with Subcortical Supratentorial Intracerebral Hemorrhage: A Nationwide Study of Real-World Data from 2016 to 2022
Background: Neurosurgical interventions are often indicated for patients with subcortical, supratentorial intracerebral hemorrhage (ICH); however, the optimal treatment modality is controversial. Whether minimally invasive surgery (MIS) may be superior to conventional craniotomy (CC) or decompressive craniectomy (DC) in real-world clinical practice is unknown. Methods: This was a retrospective cohort study of hospitalization data from the 2016–22 Nationwide Readmissions Database. International Classification of Diseases—10th edition (ICD-10) codes were used to identify patients with primary supratentorial subcortical ICH who underwent neurosurgical treatment. Patients with ICH in other brain compartments (other than intraventricular hemorrhage) were excluded. Coprimary outcomes were routine discharge to home without rehabilitation needs (excellent outcome) and in-hospital mortality. Outcomes were compared between MIS versus CC and MIS versus DC, with multivariable adjustments for patient demographics and comorbidities. Results: A total of 3829 patients were identified; 418 underwent MIS (10.9%), 2167 (56.6%) underwent CC, and 1244 (32.5%) underwent DC. Compared to CC patients, MIS patients were less likely female (p = 0.004) but otherwise had similar patient characteristics; compared to DC patients, MIS patients were older, less likely female, more likely to have mental status abnormalities, more likely to have underlying dementia, less likely to undergo external ventricular drainage, more likely to have vascular risk factors (hypertension, hyperlipidemia, diabetes), and less likely to have underlying coagulopathy (all p < 0.05). After multivariable adjustments, MIS patients had higher odds of excellent outcomes compared to CC (OR 1.99 [95%CI 1.06–3.30], p = 0.039), and similar odds compared to DC (OR 1.10 [95%CI 0.66–1.86], p = 0.73). In terms of in-hospital mortality, MIS had lower odds compared to DC (OR 0.63 [95%CI 0.41–0.96], p = 0.032) and similar odds compared to CC (OR 0.81 [95%CI 0.56–1.18], p = 0.26). Conclusions: For patients with subcortical, supratentorial ICH requiring surgical evacuation, MIS was associated with higherhigher rates of excellent outcomes compared to CC and lower rates of in-hospital mortality compared to DC. However, since key variables such as hematoma size and symptom severity were not available, residual confounding could not be excluded, and results should be interpreted cautiously. Dedicated prospective or randomized studies are needed to confirm these findings.
- 19 April 2025
- Published by Elsevier in Academic Radiology
- Vol. 32  (8) , 4480-4485
Financial Compensation of PhD Research Faculty in Academic Radiology: Trends and Disparities in the U.S.
- 19 April 2025
- Published by Elsevier in Academic Radiology
- Vol. 32  (8) , 4480-4485
Financial Compensation of PhD Research Faculty in Academic Radiology: Trends and Disparities in the U.S.
- 25 February 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104  (4) , e209774
Author Response: Thrombectomy vs Medical Management for Posterior Cerebral Artery Stroke: Systematic Review, Meta-Analysis, and Real-World Data
- 25 February 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104  (4) , e209774
Author Response: Thrombectomy vs Medical Management for Posterior Cerebral Artery Stroke: Systematic Review, Meta-Analysis, and Real-World Data